About Angiocare
Angiocare was founded in 2003 and is based in Eemnes, Netherlands. Medical devices are distributed by the company within specialties such as cardiology, interventional radiology, oncology, and neurointervention. Healthcare professionals and hospital administrations are served through an extensive product portfolio that includes cutting-edge technologies. Operations emphasize partnerships with established firms, while support is provided by a team of experienced staff to ensure reliable service delivery in the evolving healthcare sector.
- Headquarter Eemnes, Netherlands
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Angiocare B.V.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Angiocare
Detailed funding history for Angiocare
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Angiocare
Angiocare has secured backing from 1 investor. Prominent investors backing the company include Uniphar.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Speciality drugs are distributed throughout Ireland by Uniphar.
|
Locked | Locked | Locked |
Investor details for Angiocare
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Angiocare
Investment portfolio details for Angiocare
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Angiocare
Detailed financials for Angiocare
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Angiocare Comparisons
Peer comparison for Angiocare
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Angiocare
Detailed competitors of Angiocare
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Angiocare
Complete news archive for Angiocare
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Angiocare
Angiocare was founded in 2003.
Angiocare is headquartered in Eemnes, Netherlands. It is registered at Eemnes, Utrecht, Netherlands.
Jan Willem Jongma is the current CEO of Angiocare.
Angiocare was founded in 2003 and is based in Eemnes, Netherlands. Medical devices are distributed by the company within specialties such as cardiology, interventional radiology, oncology, and neurointervention. Healthcare professionals and hospital administrations are served through an extensive product portfolio that includes cutting-edge technologies. Operations emphasize partnerships with established firms, while support is provided by a team of experienced staff to ensure reliable service delivery in the evolving healthcare sector.
Angiocare has 1 investor. Key investors include Uniphar.